CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 9th Annual BIO CEO & Investor Conference on February 14, 2007 at 10:30 a.m. ET at the at The Waldorf=Astoria in New York.
